MODERN APPROACHES TO THE DIAGNOSIS AND LONG-TERM MANAGEMENT OF HYPOTHYROIDISM AND HYPERTHYROIDISM IN CLINICAL PRACTICE
Keywords:
Hypothyroidism, Hyperthyroidism, Thyroid dysfunction, Levothyroxine therapy, Graves’ disease, Thyroiditis, Subclinical hypothyroidismAbstract
Hypothyroidism and hyperthyroidism are among the most common endocrine disorders associated with thyroid gland dysfunction and are frequently encountered in clinical practice. Effective management of these conditions requires accurate diagnosis, individualized treatment strategies, and long-term follow-up. Subclinical hypothyroidism carries a risk of progression to overt disease over time, while hyperthyroidism, especially in elderly patients, may be complicated by cardiac arrhythmias and decreased bone density.
Levothyroxine is the mainstay of treatment for hypothyroidism, and its dosage is determined individually based on laboratory parameters. The management of hyperthyroidism depends on the etiology and the patient’s general condition and may include pharmacological therapy, radioactive iodine treatment, or surgical intervention. This article analyzes the importance of a patient-centered approach, individualized therapy, and monitoring in the management of thyroid diseases based on modern scientific sources.
References
Ross DS, et al. Diagnosis and management of hyperthyroidism. N Engl J Med. 2022;386:1531–1541.
Garber JR, et al. Clinical practice guidelines for hypothyroidism in adults. Thyroid. 2012;22:1200–1235.
Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008;29:76–131.
Bahn RS, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association. Thyroid. 2011;21:593–646.
Vanderpump MPJ. Epidemiology of thyroid disease. Br Med Bull. 2011;99:39–51.
Pearce EN, et al. Thyroid function in pregnancy. N Engl J Med. 2013;368:2446–2457.
Alexander EK, et al. Guidelines for the treatment of subclinical hypothyroidism in pregnancy. J Clin Endocrinol Metab. 2017;102:3607–3616.
Chaker L, et al. Hypothyroidism. Lancet. 2017;390:1550–1562.
Brent GA. Clinical practice. Graves’ disease. N Engl J Med. 2008;358:2594–2605.
Bartalena L, et al. Guidelines for diagnosis and management of Graves’ orbitopathy. Eur Thyroid J. 2016;5:9–26.
McLeod DS, Cooper DS. The incidence and prevalence of thyroid autoimmunity. Endocrine. 2012;42:1–7.
Pearce EN, et al. Iodine deficiency and thyroid disorders. Endocr Rev. 2012;33:85–121.
Hollowell JG, et al. Serum TSH, T4, and thyroid antibodies in the United States population. J Clin Endocrinol Metab. 2002;87:489–499.
Vanderpump MPJ, Tunbridge WMG. Epidemiology of autoimmune thyroid disease. Br Med Bull. 1995;51:125–139.
Burch HB, et al. Management of hyperthyroidism in the elderly. J Clin Endocrinol Metab. 2012;97:543–551.
Cooper DS. Antithyroid drugs. N Engl J Med. 2005;352:905–917.
Bahn RS, et al. Management of Graves’ disease: a review. JAMA. 2010;304:243–250.
Fatourechi V, et al. Long-term follow-up of patients with Graves’ disease. Mayo Clin Proc. 2000;75:952–956.
Tunbridge WMG, et al. The spectrum of thyroid disease in the community. Clin Endocrinol (Oxf). 1977;7:481–493.
Smith TJ, Hegedüs L. Graves’ disease. N Engl J Med. 2016;375:1552–1565.
Ross DS. Radioactive iodine therapy for hyperthyroidism. N Engl J Med. 2011;364:542–550.
Lazarus JH. Thyroid disorders in pregnancy. BMJ. 2010;341:c3439.
Azizi F, et al. Subclinical hypothyroidism: treatment recommendations. Endocr Pract. 2011;17:789–799.
Azerbaijan
Türkiye
Uzbekistan
Kazakhstan
Turkmenistan
Kyrgyzstan
Republic of Korea
Japan
India
United States of America
Kosovo